Transcreek Chemicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 31-12-2024
- Paid Up Capital ₹ 0.10 M
as on 31-12-2024
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -94.62%
(FY 2021)
- Profit 102.67%
(FY 2021)
- Ebitda 91.61%
(FY 2021)
- Net Worth 2.91%
(FY 2021)
- Total Assets -20.59%
(FY 2021)
About Transcreek Chemicals
The Corporate was formerly known as Trans Creek Multiservices Private Limited. The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ajit Nair and Velloth Krishnanunni serve as directors at the Company.
- CIN/LLPIN
U74120MH2012PTC235142
- Company No.
235142
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Aug 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Transcreek Chemicals Private Limited offer?
Transcreek Chemicals Private Limited offers a wide range of products and services, including Bricks & Construction Aggregates, Magnesia Brick, Zeolites, Zeolite Powder, Insulation Material, Acoustic Insulation Material, Construction Chemical, Calcium Chloride, Insulation Foams, Insulated Rock Wool.
Who are the key members and board of directors at Transcreek Chemicals?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ajit Nair | Director | 30-Aug-2012 | Current |
Velloth Krishnanunni | Director | 07-Jul-2021 | Current |
Financial Performance of Transcreek Chemicals.
Transcreek Chemicals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 94.62% decrease. The company also saw a substantial improvement in profitability, with a 102.67% increase in profit. The company's net worth moved up by a moderate rise of 2.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Transcreek Chemicals?
In 2020, Transcreek Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Transcreek Chemicals?
Unlock and access historical data on people associated with Transcreek Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Transcreek Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Transcreek Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.